The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?

समान संसाधन

• Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak
  द्वारा: Zingone, Fabiana, और अन्य
  प्रकाशित: (2020)
• Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
  द्वारा: Barberio, Brigida, और अन्य
  प्रकाशित: (2021)
• Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study
  द्वारा: Zingone, Fabiana, और अन्य
  प्रकाशित: (2020)
• Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice
  द्वारा: Zingone, Fabiana, और अन्य
  प्रकाशित: (2020)
• Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study
  द्वारा: Massimi, Davide, और अन्य
  प्रकाशित: (2021)